Page 2 - Adi Zuloff Shani News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Adi zuloff shani. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Adi Zuloff Shani Today - Breaking & Trending Today

Podcast: Clearmind's Non-Hallucinogenic Psychoactive Molecule Could Become A Solution For Addictive Behaviors - SciSparc (NASDAQ:SPRC), Clearmind Medicine (NASDAQ:CMND)

....

Mark Haden , Clearmind Medicine , Adi Zuloff Shani , Zuloff Shani , Benzinga Psychedelics , Alcohol Use Disorder , Path For Taking ,

Clearmind Medicine Submits Three Additional International

New patent applications build upon Clearmind’s broad IP protection in the psychedelic space Vancouver, Canada, Feb. 27, 2024 (GLOBE NEWSWIRE) . ....

British Columbia , United States , Adi Zuloff Shani , Clearmind Medicine Inc , Medicine Inc , Trademark Office , Canadian Securities Exchange , Frankfurt Stock Exchange , Scisparc Ltd , Patent Cooperation Treaty , United States Patent , Chief Executive Officer , Nasdaq Cmnd , Learmind Medicine Inc ,

Clearmind Medicine Submits Three Additional International Patent Applications for Innovative MDMA, Ibogaine and Ketamine Compounds

Clearmind Medicine Submits Three Additional International Patent Applications for Innovative MDMA, Ibogaine and Ketamine Compounds
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

British Columbia , United States , Adi Zuloff Shani , Trademark Office , Canadian Securities Exchange , Frankfurt Stock Exchange , Scisparc Ltd , Clearmind Medicine Inc , Medicine Inc , Exchange Commission , Patent Cooperation Treaty , United States Patent , Chief Executive Officer , Looking Statements , Private Securities Litigation Reform Act ,

EXCLUSIVE: Psychedelic-Focused Firm Clearmind Medicine Submits Three New International Patent Applications For MDMA, Ibogaine And Ketamine Compounds - Clearmind Medicine (NASDAQ:CMND)

Patent applications by Clearmind Medicine for novel compositions in collaboration with SciSparc. Clearmind's CEO, highlights the significant expansion of IP protection. ....

United States , Adi Zuloff Shani , Scisparc Ltd , Ministry Of Health Israel , Trademark Office , Clearmind Medicine , Patent Cooperation Treaty , United States Patent ,

EXCLUSIVE: Psychedelic-Focused Firm Clearmind Medicine Submits Three New International Patent Applications For MDMA, Ibogaine And Ketamine Compounds

On Tuesday, Clearmind Medicine Inc (NASDAQ:CMND) submitted three additional patent applications under the international Patent Cooperation Treaty (PCT) as part of its ongoing collaboration with SciSparc Ltd (NASDAQ:SPRC). The patent applications refer to novel proprietary compositions of 3,4-methylenedioxymethamphetamine (MDMA), Ibogaine, and Ketamine, each with Palmitoylethanolamide (PEA), the active ingredient of SciSparc’s proprietary CannAmide. These were previously filed as provisional pate ....

United States , Gerd Altman , Adi Zuloff Shani , Trademark Office , Scisparc Ltd , Ministry Of Health Israel , Clearmind Medicine Inc , Patent Cooperation Treaty , United States Patent , Clearmind Medicine , Stock Market Game , Benzinga Pro , Day Trial , Ibogaine And Ketamine Compounds , Patent Applications , Clearmind Medicine , Alcohol Use Disorder ,